PE20020265A1 - Combinaciones de carboxialquileter - inhibidor de acat - Google Patents

Combinaciones de carboxialquileter - inhibidor de acat

Info

Publication number
PE20020265A1
PE20020265A1 PE2001000517A PE2001000517A PE20020265A1 PE 20020265 A1 PE20020265 A1 PE 20020265A1 PE 2001000517 A PE2001000517 A PE 2001000517A PE 2001000517 A PE2001000517 A PE 2001000517A PE 20020265 A1 PE20020265 A1 PE 20020265A1
Authority
PE
Peru
Prior art keywords
alkyl
phenyl
cholesterol
carboxialkyleter
cycloalkyl
Prior art date
Application number
PE2001000517A
Other languages
English (en)
Spanish (es)
Inventor
Donna Lee Zobel
Bruce Jeffrey Auerbach
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of PE20020265A1 publication Critical patent/PE20020265A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/255—Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Obesity (AREA)
  • Hospice & Palliative Care (AREA)
  • Pulmonology (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PE2001000517A 2000-06-07 2001-06-05 Combinaciones de carboxialquileter - inhibidor de acat PE20020265A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US21005600P 2000-06-07 2000-06-07

Publications (1)

Publication Number Publication Date
PE20020265A1 true PE20020265A1 (es) 2002-04-19

Family

ID=22781424

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2001000517A PE20020265A1 (es) 2000-06-07 2001-06-05 Combinaciones de carboxialquileter - inhibidor de acat

Country Status (14)

Country Link
EP (1) EP1292363A2 (ja)
JP (1) JP2003535125A (ja)
AR (1) AR034255A1 (ja)
AU (1) AU2001263003A1 (ja)
BR (1) BR0111428A (ja)
CA (1) CA2413906A1 (ja)
GT (1) GT200100106A (ja)
MX (1) MXPA02010762A (ja)
PA (1) PA8518601A1 (ja)
PE (1) PE20020265A1 (ja)
SV (1) SV2002000466A (ja)
TN (1) TNSN01085A1 (ja)
UY (1) UY26752A1 (ja)
WO (1) WO2001093845A2 (ja)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7387236B2 (en) 2001-10-09 2008-06-17 Delaware Capital Formation, Inc. Dispensing of currency

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69833971T2 (de) * 1998-01-28 2006-11-02 Warner-Lambert Co. Llc Verfahren zur behandlung der alzheimerschen krankheit

Also Published As

Publication number Publication date
JP2003535125A (ja) 2003-11-25
GT200100106A (es) 2002-05-20
BR0111428A (pt) 2003-06-10
WO2001093845A3 (en) 2002-10-10
TNSN01085A1 (en) 2005-11-10
AR034255A1 (es) 2004-02-18
EP1292363A2 (en) 2003-03-19
PA8518601A1 (es) 2002-07-30
AU2001263003A1 (en) 2001-12-17
CA2413906A1 (en) 2001-12-13
WO2001093845A2 (en) 2001-12-13
SV2002000466A (es) 2002-04-03
UY26752A1 (es) 2001-07-31
MXPA02010762A (es) 2003-03-10

Similar Documents

Publication Publication Date Title
ECSP045331A (es) Forma de presentación para administración por vía oral, para éster etílico de ácido 3?[(2-{[4-(hexiloxicarbonilamino-imino-metil)-fenilamino]-metil}-1-metil-1H-?bencimidazol-5-carbonil)-piridin-2-il-amino]-propiónico y sus sales
DK0788350T3 (da) Dannelse af små partikler
Naughton Pathophysiology and treatment of Cheyne-Stokes respiration
DK1397130T3 (da) Substituerede indolsyrederivater som inhibitorer af plasminogenaktivatorinhibitor-1 (PAI-1)
HUP9701540A1 (hu) A gasztrointesztinális keringést elősegítő gyógyászati készítmény
EA200300622A1 (ru) Производные амидов тиазолил-, оксазолил, пирролил- и имидазолилкислот, полезные в качестве ингибиторов изоферментов pde4
WO2002060875A8 (en) Nicotinamide biaryl derivatives useful as inhibitors of pde4 isozymes
JP2009522292A5 (ja)
BR0316586A (pt) Derivados de diidropirano indol-3, 4-dione e derivados de 3-ácido oxoacético 2-hidroximetilindol substituìdo como inibidores do inibidor-1 do ativador do plasminogênio (pai-1)
HUP0002514A2 (hu) [5-Aril-2-(aril-amino)-fenil]-ecetsavak és származékaik
ATE540938T1 (de) Neue benzoxazinonderivate als langwirksame betamimetika zur behandlung von atemwegserkrankungen
NZ592224A (en) Acrylamido derivatives useful as inhibitors of the mitochondrial permeability transition
PE20051160A1 (es) DERIVADOS DE BETA-AMINOACIDOS COMO INHIBIDORES DEL FACTOR Xa
NO20051011L (no) Kirale oksazol-arylpropionsyrederivater og anvendelse derav som PPAR agonister
FR2742749B1 (fr) Nouvelles phenylimidazolidines comportant notamment un radical nitrooxy ou carbonyloxy, procede et intermediaires de preparation, application comme medicaments, nouvelles utilisations et compositions pharmaceutiques
PE20020265A1 (es) Combinaciones de carboxialquileter - inhibidor de acat
EP2597083A3 (en) Selective hydroxamate based MMP inhibitors
BRPI0811245A2 (pt) Composto de carbamoilóxi-aril-alcanoil-aril-piperazinas, composições farmacêuticas que compreendem o composto, e método para tratar dor, ansiedade e depressão administrando o composto.
CA2038409C (en) Use of tenidap to inhibit activation of collagenase and to inhibit the activity of myeloperoxidase
RU2002117037A (ru) Способ получения пленочных полимерных нанокомпозиций
DE502006005426D1 (de) Substituierte imidazolin-derivate
PE47596A1 (es) Derivado de quinoxalina util en terapia
PE20011308A1 (es) Composicion que comprende un antihipertensivo y un carboxialquileter util para tratar enfermedades vasculares
CY1113162T1 (el) Χρησιμοποιηση ενωσεων c-(2-φαινυλο-κυκλοεξυλο)-μεθυλαμινης για τη θεραπεια φοβικων διαταραχων
ES2143206T3 (es) Procedimiento para la produccion de acido lipoico.

Legal Events

Date Code Title Description
FC Refusal